Study objectives-To determine whether disease specific characteristics, reflecting clinical disease severity, add to the explanation of mobility limitations in patients with specific chronic diseases. Design and setting-Cross sectional study of survey data from community dwelling elderly people, aged 55-85 years, in the Netherlands. Participants and methods-The addi-
dence that, to obtain more detailed information about the differential impact of chronic diseases on mobility, disease specific characteristics are important to take into account.
(_ Epidemliol Community Health 1 997;51:676-685)
The role of chronic diseases as determinants of mobility limitations is intuitively important, but not well defined. A higher number of chronic diseases is consistently associated with a higher prevalence of mobility limitations,1 3 and longitudinally with a higher incidence of mobility loss. 4 However, these associations do not provide information on the influence of different specific chronic diseases. Recently, more studies have been focused on associations between specific chronic diseases and mobility.`In elderly people, the specific chronic diseases that are most consistently associated with either a higher prevalence or higher incidence of mobility limitations include arthritis,2 6-9 cardiac diseases,2 4 7 9 cerebrovascular disorders,2 4 6-8 chronic obstructive pulmonary disease, 79 diabetes mellitus2 4 8 9and, to a lesser extent, cancer2 8 9and atherosclerosis.-It may, however, be doubted whether currently used measurements of chronic diseases are sufficiently detailed to obtain accurate information on the associations between specific chronic diseases and mobility. The measurement of chronic diseases in population surveys is mostly confined to self reports pertaining to the presence or absence of a specific disease. The accuracy of patients' self reports regarding the presence of chronic diseases is generally considered adequate, although this was shown to be different for specific chronic conditions.'-3 It has been stated that the clinical severity of the disease should be taken into account in studies on the associations between specific chronic diseases and mobility.4 6 Methods that are used by physicians in clinical practice can be of value in the assessment of clinical severity of chronic diseases. Physicians implicitly judge the clinical severity of a disease in their patients according to the presence of disease specific signs and symptoms. In acquiring the necessary knowledge, medical history questions are of primary importance. This is particularly the case for most chronic diseases. Surprisingly, the use of medical history questions, conditional on disease presence, as a method of improving the explanation of mobility limitations in survey studies has never been systematically evaluated. Information about the additional influence of these parameters of clinical severity is important for epidemiological research and health planning by providing a more detailed measure of chronic diseases that can be used to obtain a more precise picture of the burden of disease for both individuals and populations, and its association with outcome measures, such as mobility limitations. When the presence of certain disease specific symptoms, reflecting clinical severity, would seem to be strongly associated with mobility limitations, it may be possible to increase the accuracy ofpredictions for the future regarding the prevalence of mobility limitations, disability, and the use of health care facilities. In addition, intervention strategies directed at particularly those parameters of clinical severity of specific chronic diseases with the strongest associations with health outcomes may be developed to diminish the negative consequences of chronic diseases in the future.
In this study, we investigate whether the explanation of mobility limitations can be improved by adding questions directed at assessment of clinical severity, conditional on the self reported presence of a specific chronic disease. The influence of these parameters of clinical disease severity on the associations between chronic diseases and mobility limitations is examined for several chronic diseases that often afflict the elderly, and that have been repeatedly shown to influence physical functioning and thereby the ability of older people to live independently in the community. Seven specific chronic diseases with a high prevalence in the elderly population were selected: chronic non-specific lung disease (asthma, chronic bronchitis or pulmonary emphysema), cardiac disease (including myocardial infarction), peripheral atherosclerosis, cerebrovascular accident, diabetes mellitus, arthritis (rheumatoid arthritis or osteoarthritis) and malignant neoplasms.
The following questions will be considered: (1) Does the self reported presence of specific chronic diseases explain self reported mobility limitations in community dwelling elderly people? (2) Does the presence of signs and symptoms, reflecting clinical disease severity, add to the explanation of mobility limitations in patients with a specific chronic disease? Methods This study uses a cross sectional design. The data were collected as part of the first data collection cycle of the Longitudinal Aging Study Amsterdam (LASA),'4 a 10 year longitudinal study on predictors and consequences of changes in physical, cognitive, emotional, and social functioning in older persons.
HYPOTHESES
For the first research question, we expected the association with mobility limitations to be most pronounced for those chronic diseases ofwhich the clinical picture is characterised by symptoms of the locomotor system (stroke and arthritis), or by decreased endurance capacity (chronic non-specific lung disease, cardiac disease). The associations of the other specific chronic diseases (peripheral atherosclerosis, diabetes mellitus, and cancer) with mobility limitations are expected to be less pronounced. the best scale out of a set of nine items. The selection of the three items was based on iterative reliability analysis, in which the items with the highest item rest correlation were retained without an important influence on the reliability coefficient. To determine whether the three mobility items, which cover a range of mobility related activities necessary to maintain autonomy in daily life, are equally important for the underlying dimension "mobility limitations" in subjects with specific chronic diseases, additional analyses were performed. Factor analyses were conducted for the three mobility items for each chronic disease separately, including only those subjects who reported to have only one of the specific chronic diseases. In this way, the relative importance of the separate items as part of the underlying dimension "mobility limitations" could be compared. The factor structure proved to be comparable between the specific chronic diseases, and was not different from that in subjects without any disease. Thus, the separate mobility items can be considered to represent a general underlying dimension for subjects with different diseases, and summing the three item scores results in a global index of mobility limitations, which is equally valid for each of the specific chronic diseases studied. Although the reliability of this three item mobility scale in the total study population was adequate (Cronbach's ca 0.72), and all items loaded on one factor (all factor loadings >0.75), use of a total score in linear regression analysis was precluded by an extremely skewed frequency distribution with >60% having a total score of 0 (range 0-9), and a non-random distribution of the residuals after multiple linear regression with the score on the mobility scale as the dependent variable. Therefore, the mobility scale was dichotomised into codes 0 To answer the second research question, logistic regression analyses were performed for each specific chronic disease separately. Subjects included in each model were those without any chronic disease (reference group) and those with at least the specific disease studied (the index disease). For example, in the logistic regression model examining the additional influence of parameters of clinical severity on the explanation of mobility limitations in patients with cardiac disease, subjects included were those who reported cardiac disease to be present and those who reported no chronic disease at all. Independent variables were included in the models in four steps.
In the first step, the potential confounders sex, age, and the presence of any other chronic disease in addition to the index disease (comorbidity) were entered. In the second step, the index disease was entered. In the third step, medical treatment for the index disease was entered because of its role as a potential confounder. Finally, in the fourth step the disease specific characteristics reflecting the clinical severity of the index disease were considered for stepwise entry. Variables Table 2 shows the background characteristics of the study population. Compared with subjects without any chronic disease and adjusted for age, sex, and comorbidity, the self reported presence of diabetes is an explanatory factor for mobility limitations (step 2: OR 2.53; 95% CI 1.14, 5.62). Neither medical treatment nor disease specific characteristics of diabetes (diabetic complications) have any additional influence on the explanation of mobility limitations. However, the net explanatory power of diabetes mellitus on mobility limitations loses its significance, when medical treatment is included in the regression model (step 3: OR 2.21; 95% CI 0.43, 11.33).
In this case, colinearity between a self report of diabetes and medical treatment is probably the cause, because 95% of the subjects reporting diabetes also reports to be medically treated for the disease.
Adjusted for age, sex, and comorbidity, a history of stroke explains the presence of mobility limitations (step 2: OR 4.73; 95% CI 1.59, 14.05). This is particularly so for patients who report to be medically treated for their stroke (step 3: OR 2.96; 95% CI 1.13, 7.78). Certain disease specific characteristics, apart from medical treatment, significantly explain the association between stroke and mobility limitations. This applies to whether more than one stroke occurred (step 4: OR 4.03; 95% CI 1.25, 13.04), and the presence of visual sequelae (step 4: OR 5.45; 95% CI 1.21, 24.59). The presence of locomotor sequelae did not add significantly to the explanation of mobility limitations in stroke patients. Although this Table 4 Results of multiple logistic regression analyses of mobility limitations (odds ratios and 95% confidence intervals) on age, sex, comiorbidity and disease specific characteristics in subjects with a specific chronic disease, compared with subjects without any chronic disease
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Discussion
In the total study sample, each self reported chronic disease is significantly associated with the presence of mobility limitations. As expected, the strongest associations are found for chronic diseases of which the clinical picture includes disability (stroke and arthritis), or that are generally associated with decreased endurance capacity (chronic non-specific lung disease and cardiac disease). This finding is consistent with results from previous studies.2 69 This study, however, shows that the self reported presence of specific chronic diseases is too crude a measure to be sufficiently accurate in explaining the presence of mobility limitations. After adjustment for the potential confounders age, sex, and comorbidity, the associations between the specific chronic diseases and mobility limitations seem to be largely explained by disease specific characteristics (including medical treatment for the index disease) reflecting clinical severity of the disease.
Symptoms explaning mobility limitations in case of a positive self report of chronic non-specific lung disease (shortness of breath during light exertion, and regular disturbance of night rest) are associated with a continuously decreased endurance tolerance. This is not the case for the other symptoms of chronic non-specific lung disease (for example, coughing and wheezing), which are, at the most, only limiting during an episode. In addition, comorbidity and medical treatment for chronic nonspecific lung disease were shown to be explanatory factors for mobility limitations in patients with chronic non-specific lung disease. Thus, the association of chronic non-specific lung disease with mobility limitations can be explained by parameters of clinical disease severity (shortness of breath and disturbed night rest, as well as medical treatment) and the presence of other chronic diseases in addition to the chronic non-specific lung disease.
For cardiac disease, symptoms of angina pectoris and congestive heart failure, both associated with decreased endurance capacity, added significantly to the explanation of mobility limitations, whereas the other characteristics studied (such as a history of myocardial infarction or cardiac surgery) did not. The association between the self reported presence of cardiac disease and mobility limitations seems to be explained completely by medical treatment and specific cardiac diagnoses indicative of the clinical severity (angina pectoris and congestive heart failure), as well as by the presence of comorbidity.
For atherosclerosis, disease specific characteristics did not add to the explanation of mobility limitations. For peripheral atherosclerosis, it has been shown that the accuracy of patients' self reports, compared with general practitioners' information, is low.'0 Therefore, it might be expected that symptoms would add to the explanation of mobility limitations in this chronic disease, but this was not the case. Relevant bias can be suspected because of confusion between the Dutch words "slagaderen" (arteries) and "spataderen" (varicose veins, venous insufficiency). Venous insufficiency may also be associated with mobility limitations, but symptoms are different from those of peripheral atherosclerosis. The explanatory power of comorbidity on mobility limitations in patients reporting peripheral atherosclerosis is high, compared with that in patients with other index diseases.
In patients with diabetes mellitus, disease specific characteristics reflecting clinical severity (that is, the presence of microvascular and macrovascular complications) did not add significantly to the explanation of mobility limitations. The possibility that these disease specific characteristics, particularly macrovascular complications, could be shown to influence the explanation of mobility limitations in diabetes mellitus, was diminished by the decision not to consider the additional presence of a self report of cardiac disease or atherosclerosis as manifestations of macrovascular complications, but to include these as comorbidity. The prevalence of cardiac disease and peripheral atherosclerosis among patients with diabetes mellitus was high, compared with the prevalence in the total sample (28.8% versus 19.2% for cardiac disease, 19.0% versus 9.3% for atherosclerosis), and compared with the prevalence of macrovascular complications in diabetic patients (16.6%). In contrast with the disease specific complications, the presence of comorbidity adds to the explanation of mobility limitations in patients with diabetes mellitus. The fact that virtually all diabetic patients are medically treated for the disease, which introduces the problem of colinearity in the analysis, probably explains why the association of diabetes mellitus with mobility limitations is not significant anymore, once medical treatment is entered as a potential confounder.
In contrast with expectations, the presence of locomotor sequelae in stroke patients did not add to the explanation of mobility limitations. Although the prevalence of this symptom is high (49.3%), a history of more than one stroke and the presence of visual sequelae, which were both not associated with the presence of locomotor sequelae, seem to be more important. These aspects of clinical severity largely explain the association between stroke and mobility limitations. In contrast with the results in the other index diseases, comorbidity offers no additional explanation.
In patients with arthritis, affliction of the lower body joints has the largest explanatory power on mobility limitations, as would be expected considering the content of the mobility items included. Also, a history of lower body joint surgery (an intervention with the purpose of restoring function and alleviating symptoms) adds to the explanation of mobility limitations. The conclusion that can be drawn from this cross sectional analysis is that, although joint surgery undoubtedly has a beneficial influence on functioning and symptoms, mobility is not restored fully, compared with people of the same age and sex, but without chronic diseases. The association between arthritis and mobility limitations is thus explained by certain parameters of disease severity (joint stiffness, complaints of lower body joints, and a history of surgery on the lower body joints), as well as by continuous medical treatment and the presence of comorbidity.
The cross sectional design of this study is a possible explanation for the negative results we found for patients with a history of cancer: in all prognostic categories, only survivors are included (the mean duration of time since diagnosis was approximately eight years). In the absence of haematogenous metastases and additional chronic diseases, the initial severity of cancer (as reflected by the prognostic category) does not add to the explanation of mobility limitations.
Medical treatment was adjusted for, because it was expected that the associations between the specific index diseases and mobility could be modified by treatment in both directions. However, when medical treatment was of influence (in chronic non-specific lung disease, cardiac disease, and arthritis), it was consistently associated with a higher odds for mobility limitations. A 
